JPRN-C000000317已完成2 期
Phase II clinical trials of mature B-cell neoplasms in children: A Japanese Cooperative Studies - Clinical trials of childhood B-cell lymphomas
Japanese Pediatric Leukemia/Lymphoma Studu Group(JPLSG)0 个研究点目标入组 308 人开始时间: 2006年2月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 308
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1, Down's syndrome(21 trisomy) 2, Previous malignancy of any type 3, Prior stem cell/organ transplantation 4, Congenital immunodeficiency 5, HIV positivity
研究者
相似试验
终止
1 期
BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple MyelomaMultiple MyelomaNCT04318327Novartis Pharmaceuticals96
已完成
不适用
Phase II trial as new chemotherapy regimen for bevacizumab (Bev) in combination with XELOX in unresectable colorectal cancer.unresectable colorectal cancerJPRN-UMIN000010160Tsukasa Hotta27
已完成
2 期
Phase II clinical trial of advanced stage ymphoblastic lymphoma. A Japanese Pediatric Cooperative StudyAdvanced stage lymphoblastic lymphoma of children.JPRN-UMIN000002212Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)124
撤回
2 期
Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)Asymptomatic COVID-19 Infection Laboratory-ConfirmedB-Cell NeoplasmChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaMarginal Zone LymphomaSmall Lymphocytic LymphomaSymptomatic COVID-19 Infection Laboratory-ConfirmedChronic Lymphocytic LeukemiaMantle Cell LymphomaWaldenstrom MacroglobulinemiaNCT04665115Academic and Community Cancer Research United
已完成
2 期
Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual DiseaseAdult Acute Lymphoblastic Leukemia in Complete RemissionB Acute Lymphoblastic LeukemiaPhiladelphia Chromosome PositiveMinimal Residual DiseaseNCT02458014M.D. Anderson Cancer Center36